News
Category
-
Accesswire
1upHealth Reports 2023 as Record Year of Growth; Company Now Offers Largest Set of CMS APIs in the Industry
January 9, 2024 -
PR Newswire
Burro Closes $24 Million Series B Co-Led by Catalyst Investors and Translink Capital
January 9, 2024 -
Financial Times
UK start-up Genomics raises £35mn for advanced genetic testing
January 8, 2024 -
EQS News
Eckert & Ziegler and ARTBIO Announce Manufacturing and Supply Partnership for Lead-212 Conjugates
January 8, 2024 -
PR Newswire
OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients
January 4, 2024 -
Fierce Healthcare
Devoted Health closes out 2023 with $175M series E funding round
January 1, 2024 -
Fierce Healthcare
VA deepens partnership with AppliedVR to expand access to immersive therapeutics
December 20, 2023 -
PR Newswire
Veterans Health Administration Extends Contract with AppliedVR to Continue Use of Virtual Reality for Treating Chronic Low Back Pain
December 20, 2023 -
Economic Times India
PlasmaGen Biosciences raises Rs 225 crore in equity funding
December 14, 2023 -
PR Newswire
WelbeHealth Opens First Bay Area PACE Center Serving Vulnerable Seniors in San Jose
December 12, 2023 -
PR Newswire
Fortune Announces the 2023 ‘Impact 20’ Startups That Are Making a Difference
December 12, 2023 -
Business Wire
Bicara Therapeutics Announces Oversubscribed $165 Million Series C Financing
December 12, 2023 -
Endpoints News
Exclusive: Shinobi raises $51M to take on cell therapy challenges with ex-Wugen CEO at helm, Carl June in support
December 12, 2023 -
Endpoints News
Biocon oncology spinout Bicara secures its second nine-figure financing of the year
December 12, 2023 -
Endpoints News
ARTBIO raises $90M as radiopharma field finds its footing
December 7, 2023 -
PR Newswire
ABK Biomedical announces that its Eye90 microspheres® device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA)
December 5, 2023 -
PR Newswire
Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD)
December 5, 2023 -
Oviva
A milestone in the digital health revolution: Doctors prescribe app-based obesity and diabetes care to 500,000th patient
December 4, 2023 -
PR Newswire
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
December 4, 2023 -
PR Newswire
AmplifyMD Named a Winner in Fast Company’s Next Big Things in Tech
November 30, 2023 -
PR Newswire
Eleos Health and Kipu Health Announce Partnership to Deliver AI-Powered Insights to Behavioral Health Providers
November 28, 2023 -
PR Newswire
K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer
November 15, 2023 -
The Standard
London doctors become first in the UK to ‘livestream’ surgery using robot
November 15, 2023 -
Financial Times
Biotech raises funds to find cancer treatments using transgenic mice
November 15, 2023 -
Globenewswire
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
November 15, 2023 -
PR Newswire
Capital Rx and Vida Health Partner to Launch Rx Activate, a High-Touch Chronic Condition Management Program
November 14, 2023 -
PR Newswire
NFlection Therapeutics Announces Positive Results from Phase 2b Study of NFX‑179 Topical Gel in the Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1
November 13, 2023 -
PR Newswire
Behavioral Health AI Leader Eleos Health Raises $40M Series B Round to Expand CareOps Automation Footprint
November 8, 2023 -
Endpoints News
AppliedVR is betting a new study could strengthen the case for insurance coverage of its VR chronic pain treatment
November 7, 2023 -
PR Newswire
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
November 6, 2023 -
Business Wire
AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
November 6, 2023 -
Endpoints News
Prime Medicine showcases its first in vivo editing data in monkeys and mice
October 30, 2023 -
PR Newswire
ABK Biomedical Announces First Patient Treated in its Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma
October 24, 2023 -
Boston Business Journal
FDA lifts clinical hold on LDL-lowering drug from Verve Therapeutics
October 23, 2023 -
TechCrunch
Warmly pivots from Zoom tool to directing warm leads to sales
October 19, 2023 -
GlobeNewswire
NodThera announces first patients dosed in a Phase Ib/IIa cardiovascular risk trial of NLRP3 inflammasome inhibitor NT-0796
October 16, 2023 -
Business Wire
AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations
October 10, 2023 -
PR Newswire
Rippl and McLean Hospital collaborate to build ‘first of its kind’ dementia training program
October 9, 2023 -
PR Newswire
Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials
October 6, 2023 -
Globenewswire
Kyowa Kirin to Acquire Orchard Therapeutics
October 5, 2023 -
Business Wire
Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19
October 4, 2023 -
Globenewswire
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
September 29, 2023 -
PR Newswire
Doceree raises $35 million in Series B funding, led by Creaegis with participation from Eight Roads Ventures and F-Prime Capital
September 27, 2023 -
Endpoints News
Avalyn raises $175M to test inhaler versions of IPF medicines in PhII trials
September 27, 2023 -
Globenewswire
Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studies
September 27, 2023 -
Endpoints News
Labcorp backs Adela’s $48M Series A1 to advance methylation-based head and neck cancer test
September 25, 2023 -
Nature
Peptone: finding opportunity in disorder
September 19, 2023 -
Wall Street Journal
All Pregnant Women Should Be Screened for Blood-Pressure Disorders, U.S. Advisers Say
September 19, 2023 -
Fierce Healthcare
Equip nabs additional investment to expand virtual eating disorder treatment services to adult patients
September 19, 2023 -
Globenewswire
Neumora Therapeutics Announces Pricing of Initial Public Offering
September 14, 2023 -
Newswire
Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research
September 11, 2023 -
Globenewswire
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 5, 2023 -
Eleos Health
Eleos Health and KCare Join Forces to Improve Clinician Support with CareOps Automation
August 31, 2023 -
Boston Business Journal
Substance-use treatment startup Better Life Partners completes $26.5M Series B fundraise
August 29, 2023 -
PR Newswire
Comanche Biopharma Named by Fierce Biotech as a “Fierce 15” Biotech Company of 2023
August 28, 2023 -
PR Newswire
Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia
August 23, 2023 -
Boston Business Journal
Firefly grows in wake of healthcare disruptions in southeastern Mass.
August 22, 2023 -
Business Wire
Madaket Health Releases Provider Data Exchange to Help Payers Remain Compliant with the No Surprises Act
August 17, 2023 -
PR Newswire
TraceLink Collaborates with GS1 US to Author GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3 to Support EPCIS Data Exchange
August 16, 2023 -
PR Newswire
Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia
August 16, 2023 -
BioPharma Dive
Radiopharmaceuticals for cancer: Making radiation precise
August 15, 2023 -
Business Wire
Health Plan Alliance Selects 1upHealth as Preferred Health Data Interoperability Partner
August 15, 2023 -
PR Newswire
Memorial Hermann Health System Makes a Strategic Investment in Capital Rx Customer Solutions Platform
August 10, 2023 -
Gulf Business
SoftBank-backed Proximie launches virtual robotic-assisted surgery training course
August 10, 2023 -
PR Newswire
Talkiatry and NOCD Team up to Strengthen OCD Care Journeys
August 8, 2023 -
Business Wire
Simon Data Raises Series D Funding Round to Further Develop World’s First Fully-Connected CDP
August 8, 2023 -
Behavioral Health Business
Better Life Partners Lands $26.5M for Virtual SUD, Mental Health Platform
August 7, 2023 -
Globenewswire
Avalyn Pharma Expands Executive Team with Appointment of Howard M. Lazarus, MD, FCCP to the Role of Chief Medical Officer
August 7, 2023 -
MedCity News
Talkiatry, NOCD Strike Partnership To Support Patients With OCD
August 7, 2023 -
Endpoints News
Born out of Omega push for pandemic treatments, Aerium Therapeutics enters long Covid R&D
August 4, 2023 -
Owkin
With ISO certification, Owkin demonstrates commitment to utmost quality with its AI solutions for digital pathology
August 3, 2023 -
PR Newswire
Sironax Announces Closing of $200 Million Series B Financing
August 2, 2023 -
National Venture Capital Association
Member Spotlight: F-Prime Capital
July 27, 2023 -
Globenewswire
Avalyn Pharma Invited to Present at Canaccord Genuity Annual Growth Conference
July 27, 2023 -
PRWeb
Patina teams with Humana to expand reach of convenient, relationship-centered primary care for people with Medicare
July 26, 2023 -
Business Wire
Invetx Completes Development of Canine and Feline Half-Life Extension Technology Platform that Significantly Extends Duration of Monoclonal Antibody Treatment Effect
July 25, 2023 -
Fierce Healthcare
VR helps brain tumor patients overcome “scanxiety” before brain scans, study finds
July 24, 2023 -
Business Wire
Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer
July 24, 2023 -
PR Newswire
ARTBIO and SpectronRx Enter a Collaboration to Manufacture Key Components of ARTBIO’s AlphaDirect™ Technology
July 24, 2023 -
PR Newswire
AppliedVR and National Cancer Institute Collaborate on Research Evaluating Virtual Reality for Reducing Anxiety in Primary Brain Tumor Patients During Imaging Services
July 20, 2023 -
EIN Presswire
Centivo Launches Partnership with SSM Health
July 14, 2023 -
Endpoints News
Tenpoint Therapeutics launches with $70M to restore vision with stem cell therapies and ‘reprogramming’ medicines
July 12, 2023 -
Globenewswire
NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor
July 11, 2023 -
PR Newswire
Zus Health Joins Civitas Networks for Health
July 10, 2023 -
PRWeb
Patina brings innovative primary care for people 65+ to Charlotte region; designed to help individuals thrive & remain independent
July 7, 2023 -
BioSpace
Ultragenyx Announces First Patients Dosed in Phase 3 Program Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)
July 6, 2023 -
PR Newswire
Centivo Launches Partnership with SSM Health in the Fond du Lac Market to Offer Wisconsin Businesses and Employees More Affordable, High-Quality Healthcare
July 6, 2023 -
PR Newswire
China NMPA approves RareStone’s pitolisant (Wakix) for the treatment of narcolepsy
July 4, 2023 -
BioSpace
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
July 3, 2023 -
PR Newswire
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
July 2, 2023